N-[bis(4-fluorophenyl)methyl]-2-[4-(6-chloro-2-pyridinyl)piperazin-1-yl]ethanamine
C24H25ClF2N4 — CID 19030667
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[bis(4-fluorophenyl)methyl]-2-[4-(6-chloro-2-pyridinyl)piperazin-1-yl]ethanamine
N-[bis(4-fluorophenyl)methyl]-2-[4-(6-chloro-2-pyridinyl)piperazin-1-yl]ethanamine (PubChem CID 19030667) has the molecular formula C24H25ClF2N4 and a molecular weight of 442.94 g/mol. Its IUPAC name is N-[bis(4-fluorophenyl)methyl]-2-[4-(6-chloro-2-pyridinyl)piperazin-1-yl]ethanamine.
Molecular Properties
| Compound Name | N-[bis(4-fluorophenyl)methyl]-2-[4-(6-chloro-2-pyridinyl)piperazin-1-yl]ethanamine |
|---|---|
| PubChem CID | 19030667 |
| Molecular Formula | C24H25ClF2N4 |
| Molecular Weight | 442.94 g/mol |
| Exact Mass | 442.17 |
| IUPAC Name | N-[bis(4-fluorophenyl)methyl]-2-[4-(6-chloro-2-pyridinyl)piperazin-1-yl]ethanamine |
| SMILES | Fc1ccc(C(NCCN2CCN(c3cccc(Cl)n3)CC2)c2ccc(F)cc2)cc1 |
| InChI | InChI=1S/C24H25ClF2N4/c25-22-2-1-3-23(29-22)31-16-14-30(15-17-31)13-12-28-24(18-4-8-20(26)9-5-18)19-6-10-21(27)11-7-19/h1-11,24,28H,12-17H2 |
| InChIKey | JZONFHMPZMSZHA-UHFFFAOYSA-N |
| XLogP | 4.51 |
| TPSA | 31.40 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 442.94 |
| LogP ≤ 5 | 4.51 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 19030667 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.